Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
PAT: Troublesome Times
Company has posted a loss of Rs 0.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 40.0% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Ortin Labs Share Price Update
Ortin Global Ltd. share price moved down by -0.77% from its previous close of Rs 11.72. Ortin Global Ltd. stock last traded price is 11.63
Share Price
Value
Today/Current/Last
11.6311.38
Previous Day
11.7211.97
InsightsOrtin Labs
Do you find these insights useful?
hate it
meh
love it
Key Metrics
PE Ratio
(x)
-11.17
EPS - TTM
(₹)
-1.04
MCap
(₹ Cr.)
9.23
Sectoral MCap Rank
109
PB Ratio
(x)
0.39
Div Yield
(%)
0.00
Face Value
(₹)
10.00
Beta
Beta
1 Month
-0.21
3 Months
1.51
6 Months
1.39
1 Year
1.24
3 Years
1.51
-0.21
VWAP
(₹)
11.49
52W H/L
(₹)
24.82 / 9.64
BV/Share
(₹)
30.15
MCap/Sales
0.56
52W H/L
BV/Share
MCap/Sales
PE Ratio
(x)
-11.48
EPS - TTM
(₹)
-1.04
MCap
(₹ Cr.)
9.72
Sectoral MCap Rank
174
PB Ratio
(x)
0.40
Div Yield
(%)
0.00
Face Value
(₹)
10.00
Beta
Beta
1 Month
0.77
3 Months
1.98
6 Months
1.54
1 Year
1.08
3 Years
1.42
0.77
VWAP
(₹)
11.44
52W H/L
(₹)
24.96 / 9.57
BV/Share
(₹)
30.15
MCap/Sales
0.56
52W H/L
BV/Share
MCap/Sales
Key Metrics
PE Ratio
(x)
-11.17
EPS - TTM
(₹)
-1.04
Dividend Yield
(%)
0.00
VWAP
(₹)
11.49
PB Ratio
(x)
0.39
MCap
(₹ Cr.)
9.23
Face Value
(₹)
10.00
BV/Share
(₹)
30.15
Sectoral MCap Rank
109
52W H/L
(₹)
24.82 / 9.64
Beta
Beta
1 Month
-0.21
3 Months
1.51
6 Months
1.39
1 Year
1.24
3 Years
1.51
-0.21
MCap/Sales
0.56
PE Ratio
(x)
-11.48
EPS - TTM
(₹)
-1.04
Dividend Yield
(%)
0.00
VWAP
(₹)
11.44
PB Ratio
(x)
0.40
MCap
(₹ Cr.)
9.72
Face Value
(₹)
10.00
BV/Share
(₹)
30.15
Sectoral MCap Rank
174
52W H/L
(₹)
24.96 / 9.57
Beta
Beta
1 Month
0.77
3 Months
1.98
6 Months
1.54
1 Year
1.08
3 Years
1.42
0.77
MCap/Sales
0.56
Ortin Labs Share Price Returns
1 Day
-0.77%
1 Week
-2.43%
1 Month
4.3%
3 Months
6.02%
1 Year
-42.14%
3 Years
-44.88%
5 Years
-22.47%
1 Day
-4.92%
1 Week
N.A.
1 Month
1.16%
3 Months
3.45%
1 Year
-43.04%
3 Years
-46.57%
5 Years
-24.13%
ET Stock ScreenersTop Score Companies
Check whether Ortin Labs belongs to analysts' top-rated companies list?
Company has posted a loss of Rs 0.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 40.0% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
Annual
FY 2012
Return on Equity (%)
18.85
Return on Capital Employed (%)
34.77
Return on Assets (%)
5.67
Interest Coverage Ratio (x)
3.63
Asset Turnover Ratio (x)
-
Price to Earnings (x)
10.44
Price to Book (x)
1.97
EV/EBITDA (x)
5.27
EBITDA Margin (%)
13.81
Annual
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Return on Equity (%)
-42.80
-284.74
-0.86
-3.63
8.32
Return on Capital Employed (%)
-38.33
-142.49
2.19
2.14
7.54
Return on Assets (%)
-22.38
-120.65
-0.44
-1.92
4.44
Interest Coverage Ratio (x)
-311.96
-13.20
1.42
0.71
1.48
Asset Turnover Ratio (x)
0.07
0.15
0.29
0.39
0.12
Price to Earnings (x)
-9.60
-1.80
-151.52
-46.30
27.78
Price to Book (x)
4.11
5.13
1.30
1.68
2.31
EV/EBITDA (x)
-9.49
-2.19
36.13
41.66
25.47
EBITDA Margin (%)
-219.63
-301.38
9.34
6.97
15.85
Financial InsightsOrtin Labs
Income (P&L)
Ratios
PAT: Troublesome Times
Company has posted a loss of Rs 0.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 40.0% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
Ortin Global Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 9.53 Crore) operating in Pharmaceuticals sector. Ortin Global Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals for the year ending 31-Mar-2024.For the quarter ended 31-03-2025, the company has reported a Standalone Total Income of Rs .09 Crore, up 157.61 % from last quarter Total Income of Rs .03 Crore and down 72.07 % from last year same quarter Total Income of Rs .31 Crore. Company has reported net profit after tax of Rs -.16 Crore in latest quarter.The company’s top management includes Mr.S Murali Krishna Murthy, Mr.S Srinivas Kumar, Mr.Pramod Dnyandeo Waghe, Mr.S Balaji Venkateswarlu, Mr.Shashikant Shankarrao Igave, Mr.B Gopal Reddy, Mr.Murali Krishna Rayaprolu, Ms.Pottur Sujatha, Mr.Pratik Bharatbhai Panchal, Mr.Ramesh Joshi, Mr.Rutvikbhai Mukeshbhai Beladiya, Mrs.Smitaben Suthar, Mr.S Srinivas Kumar. Company has Sathuluri & Co. as its auditors. As on 31-03-2025, the company has a total of .81 Crore shares outstanding.Ortin Labs Share Price Today is Rs. 11.63. On previous day, the Ortin Labs Share Price (NSE) closed at Rs. 11.87, featuring among the most traded securities on the National Stock Exchange.
Shareholdings: As of 31st Mar, 2025, the promoter held 1.23% of the stake in Ortin Labs shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Ortin Labs stocks was 6.53% as compared to 6.25% in Dec 2024 with increase of 0.28%. The domestic institutional investors (DII) holdings on 31st Mar, 2025 was 0.0% as compared to 0.0% in Dec 2024 with null of 0.0%. Out of the total DII holdings in Ortin Labs shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Ortin Labs stock price is reflected on both the exchanges - BSE and NSE.
Dividend, Bonus & Split Information: Ortin Labs Dividend: Ever since 1986, Ortin Labs dividends has been paid out around 6 times. As on 04 Jul, 2025, 01:03 PM IST, The overall dividend yield for Ortin Labs stands at 0.0%. The last dividend paid was on October 13, 2011 (Rs. 0.5). The Earnings Per Share (EPS) for quarter ending 31st Mar 2025 is Rs. -1.04.
Ortin Labs Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.
Stock Forecast: After showing 0.13 Cr. of sales and 280.0% of quarterly net profit, there have been multiple ups and downs in the Ortin Labs stock prices in the past few weeks. For example, Ortin Labs stock price on 26th of June 2025 was around Rs. 11.07. Ortin Labs share price now stands at an average of Rs. 11.63. Judging by last week's performance, stock is in up trend.
Ortin Labs has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Ortin Labs share.
Historical Prices and Performance: Ortin Labs, incorporated in 1986 is a Small Cap company (with a market cap of Rs. 9.65) operating in Pharmaceuticals sector. The Return of Equity (ROE) in last five financial years given by Ortin Labs stock was -42.8%, -284.74%, -0.86%, -3.63% and 8.32% respectively. The Ortin Labs share gave a 3 year return of -38.12% as compared to Nifty 50 which gave a return of 51.51%. Ortin Labs announced 5.0% final dividend on October 13, 2011.
Key Metrics: PE Ratio of Ortin Labs is -11.4 Prices/Sales Ratio of Ortin Labs is 0.56 Price/Book Ratio of Ortin Labs is 0.39
Peer Insights: Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Ortin Labs, major competitors and peers include Alpa Labs, Bafna Pharma, Aarey Drugs and Krebs Biochem. As of Dec 2024, the dividend yield of Ortin Labs stands at 0.0% while Alpa Labs, Bafna Pharma, Aarey Drugs and Krebs Biochem stand at 0.0%, 0.0%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -11.4 and 0.39 respectively.
Leadership of Ortin Labs : S Srinivas Kumar is Chief Financial Officer Murali Krishna Rayaprolu is Independent Director S Murali Krishna Murthy is Managing Director S Srinivas Kumar is Whole Time Director S Balaji Venkateswarlu is Non Executive Director B Gopal Reddy is Independent Director Pottur Sujatha is Independent Director Pramod Dnyandeo Waghe is Non Executive Director Shashikant Shankarrao Igave is Non Executive Director Rutvikbhai Mukeshbhai Beladiya is Additional Director Smitaben Suthar is Additional Director Pratik Bharatbhai Panchal is Additional Director Ramesh Joshi is Additional Director
Ortin Labs share price is Rs 11.63 as on 04 Jul, 2025, 01:03 PM IST. Ortin Labs share price is down by 0.77% based on previous share price of Rs. 11.87. In last 1 Month, Ortin Labs share price moved up by 4.30%.
2. What are the returns for Ortin Labs share?
Return Performance of Ortin Labs Shares:
1 Week: Ortin Labs share price moved down by 2.43%
1 Month: Ortin Labs share price moved up by 4.30%
3 Month: Ortin Labs share price moved up by 6.02%
6 Month: Ortin Labs share price moved down by 34.88%
3. What is the PE & PB ratio of Ortin Labs?
The PE ratio of Ortin Labs stands at -11.26, while the PB ratio is 4.82.
4. What has been highest price of Ortin Labs share in last 52 weeks?
52 Week high of Ortin Labs share is Rs 24.82 while 52 week low is Rs 9.64
5. What is the market cap of Ortin Labs?
Market Capitalization of Ortin Labs stock is Rs 9.23 Cr.
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.